Hybrid Capture 2 human papillomavirus testing of fine needle aspiration cytology of head and neck squamous cell carcinomas

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Background Human papillomavirus (HPV) positive head and neck squamous cell carcinoma (HNSCC) accounts for 25% of HNSCCs and frequently presents with neck lymph node metastases. We investigated utilizing cytology needle rinse material for HPV DNA testing by Hybrid Capture 2 molecular testing (HC2) as an alternative to p16 immunohistochemistry. Methods Twenty-two cases of HNSCC presenting with neck lymph node metastasis were prospectively identified by assessment of Diff Quik stained cytology smears. An aliquot of the needle rinse material from the lymph node was analyzed for HPV status using standard HC2 protocol. P16 status was determined with immunohistochemistry on the cell block and/or surgically obtained tumor. Results The mean age of patients with p16 negative HNSCC was 7 years older than p16 positive disease (Table). Primary tumor subsites were as follows: 17 oropharynx, 1 hypophayrnx, 3 larynx, and 1 oral cavity (Table). All ten p16 negative patients had a history of smoking compared with 33% of p16 positive. Only 3 (25%) of p16 positive tumors demonstrated keratinization, whereas 90% of the p16 negative tumors keratinized (Fig. 1). Twelve of 22 HNSCC cases (55%) were p16 positive, of which 7 (58%) tested positive for HPV by HC2. Ten cases (45%) were negative for p16, all of which were negative for HPV by HC2 (Table). Conclusion Molecular testing for HPV using HC2 on needle rinse material of FNA of HNSCC is a useful method of determining HPV status in HNSCC. Diagn. Cytopathol. 2015;43:683-687.

Original languageEnglish (US)
Pages (from-to)683-687
Number of pages5
JournalDiagnostic Cytopathology
Volume43
Issue number9
DOIs
StatePublished - Sep 1 2015

Fingerprint

Fine Needle Biopsy
Cell Biology
Needles
Lymph Nodes
Neoplasms
Neck
Immunohistochemistry
Neoplasm Metastasis
Oropharynx
Larynx
Carcinoma, squamous cell of head and neck
Mouth
Smoking
DNA

Keywords

  • head and neck squamous cell carcinoma
  • HPV
  • Hybrid Capture 2

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Histology

Cite this

@article{205ed34fdaba4f55947375b0a6d14c78,
title = "Hybrid Capture 2 human papillomavirus testing of fine needle aspiration cytology of head and neck squamous cell carcinomas",
abstract = "Background Human papillomavirus (HPV) positive head and neck squamous cell carcinoma (HNSCC) accounts for 25{\%} of HNSCCs and frequently presents with neck lymph node metastases. We investigated utilizing cytology needle rinse material for HPV DNA testing by Hybrid Capture 2 molecular testing (HC2) as an alternative to p16 immunohistochemistry. Methods Twenty-two cases of HNSCC presenting with neck lymph node metastasis were prospectively identified by assessment of Diff Quik stained cytology smears. An aliquot of the needle rinse material from the lymph node was analyzed for HPV status using standard HC2 protocol. P16 status was determined with immunohistochemistry on the cell block and/or surgically obtained tumor. Results The mean age of patients with p16 negative HNSCC was 7 years older than p16 positive disease (Table). Primary tumor subsites were as follows: 17 oropharynx, 1 hypophayrnx, 3 larynx, and 1 oral cavity (Table). All ten p16 negative patients had a history of smoking compared with 33{\%} of p16 positive. Only 3 (25{\%}) of p16 positive tumors demonstrated keratinization, whereas 90{\%} of the p16 negative tumors keratinized (Fig. 1). Twelve of 22 HNSCC cases (55{\%}) were p16 positive, of which 7 (58{\%}) tested positive for HPV by HC2. Ten cases (45{\%}) were negative for p16, all of which were negative for HPV by HC2 (Table). Conclusion Molecular testing for HPV using HC2 on needle rinse material of FNA of HNSCC is a useful method of determining HPV status in HNSCC. Diagn. Cytopathol. 2015;43:683-687.",
keywords = "head and neck squamous cell carcinoma, HPV, Hybrid Capture 2",
author = "Laleh Hakima and Esther Adler and Prystowsky, {Michael B.} and Schiff, {Bradley A.} and Nicolas Schlecht and Fox, {Amy S.} and Suhrland, {Mark J.} and Khader, {Samer N.}",
year = "2015",
month = "9",
day = "1",
doi = "10.1002/dc.23278",
language = "English (US)",
volume = "43",
pages = "683--687",
journal = "Diagnostic Cytopathology",
issn = "8755-1039",
publisher = "Wiley-Liss Inc.",
number = "9",

}

TY - JOUR

T1 - Hybrid Capture 2 human papillomavirus testing of fine needle aspiration cytology of head and neck squamous cell carcinomas

AU - Hakima, Laleh

AU - Adler, Esther

AU - Prystowsky, Michael B.

AU - Schiff, Bradley A.

AU - Schlecht, Nicolas

AU - Fox, Amy S.

AU - Suhrland, Mark J.

AU - Khader, Samer N.

PY - 2015/9/1

Y1 - 2015/9/1

N2 - Background Human papillomavirus (HPV) positive head and neck squamous cell carcinoma (HNSCC) accounts for 25% of HNSCCs and frequently presents with neck lymph node metastases. We investigated utilizing cytology needle rinse material for HPV DNA testing by Hybrid Capture 2 molecular testing (HC2) as an alternative to p16 immunohistochemistry. Methods Twenty-two cases of HNSCC presenting with neck lymph node metastasis were prospectively identified by assessment of Diff Quik stained cytology smears. An aliquot of the needle rinse material from the lymph node was analyzed for HPV status using standard HC2 protocol. P16 status was determined with immunohistochemistry on the cell block and/or surgically obtained tumor. Results The mean age of patients with p16 negative HNSCC was 7 years older than p16 positive disease (Table). Primary tumor subsites were as follows: 17 oropharynx, 1 hypophayrnx, 3 larynx, and 1 oral cavity (Table). All ten p16 negative patients had a history of smoking compared with 33% of p16 positive. Only 3 (25%) of p16 positive tumors demonstrated keratinization, whereas 90% of the p16 negative tumors keratinized (Fig. 1). Twelve of 22 HNSCC cases (55%) were p16 positive, of which 7 (58%) tested positive for HPV by HC2. Ten cases (45%) were negative for p16, all of which were negative for HPV by HC2 (Table). Conclusion Molecular testing for HPV using HC2 on needle rinse material of FNA of HNSCC is a useful method of determining HPV status in HNSCC. Diagn. Cytopathol. 2015;43:683-687.

AB - Background Human papillomavirus (HPV) positive head and neck squamous cell carcinoma (HNSCC) accounts for 25% of HNSCCs and frequently presents with neck lymph node metastases. We investigated utilizing cytology needle rinse material for HPV DNA testing by Hybrid Capture 2 molecular testing (HC2) as an alternative to p16 immunohistochemistry. Methods Twenty-two cases of HNSCC presenting with neck lymph node metastasis were prospectively identified by assessment of Diff Quik stained cytology smears. An aliquot of the needle rinse material from the lymph node was analyzed for HPV status using standard HC2 protocol. P16 status was determined with immunohistochemistry on the cell block and/or surgically obtained tumor. Results The mean age of patients with p16 negative HNSCC was 7 years older than p16 positive disease (Table). Primary tumor subsites were as follows: 17 oropharynx, 1 hypophayrnx, 3 larynx, and 1 oral cavity (Table). All ten p16 negative patients had a history of smoking compared with 33% of p16 positive. Only 3 (25%) of p16 positive tumors demonstrated keratinization, whereas 90% of the p16 negative tumors keratinized (Fig. 1). Twelve of 22 HNSCC cases (55%) were p16 positive, of which 7 (58%) tested positive for HPV by HC2. Ten cases (45%) were negative for p16, all of which were negative for HPV by HC2 (Table). Conclusion Molecular testing for HPV using HC2 on needle rinse material of FNA of HNSCC is a useful method of determining HPV status in HNSCC. Diagn. Cytopathol. 2015;43:683-687.

KW - head and neck squamous cell carcinoma

KW - HPV

KW - Hybrid Capture 2

UR - http://www.scopus.com/inward/record.url?scp=84939265466&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84939265466&partnerID=8YFLogxK

U2 - 10.1002/dc.23278

DO - 10.1002/dc.23278

M3 - Article

C2 - 25964135

AN - SCOPUS:84939265466

VL - 43

SP - 683

EP - 687

JO - Diagnostic Cytopathology

JF - Diagnostic Cytopathology

SN - 8755-1039

IS - 9

ER -